Course Overview
This content was accurate at the time of release, 18 July 2023. Accreditation for this course expired on 18 August 2023. If you would still like an activity completion certificate, send your request to [email protected].
This event took place on July 19th, 2023
First schedule: 1pm EDT / 7pm CEST
Second schedule: 4pm EDT / 10pm CEST
This expert webinar is designed to improve knowledge around the recommendations for exercise and sports participation for patients with hypertrophic cardiomyopathy (HCM). It assists secondary healthcare professionals to:
- better understand the exercise physiology in HCM
- describe the overall risks for HCM patients participating in sports and exercise, and make appropriate recommendations and expert referral for further risk assessment
This webinar is 60 minutes duration.
Target audience
Cardiologists, echocardiographers, electrophysiologists, cardiac sonographers, cardiology nurses, nurse practitioners, registered nurses, physician assistants, pediatricians, pediatric nurses.
Funding disclosure
This activity is supported by educational grant funding from Bristol Myers Squibb and Cytokinetics. Learners may participate in this educational activity free of charge.
- Welcome and overview of exercise physiology in HCM
- Effects of chronic exercise on HCM phenotype
- Mechanisms of ventricular tachycardia/fibrillation and exercise-related sudden cardiac death in the general HCM population
- What is the overall risk of exercise for patients with HCM?
- Current guideline recommendations for exercise in HCM
- Personalized recommendations for exercise in HCM – the way forward?
- Q&A and closing remarks
By the end of this activity, attendees will be able to:
- outline exercise physiology and effects in patients with HCM
- summarize the potential positive and negative impacts of chronic exercise in patients with HCM
- describe the current guideline recommendations for physical activity for HCM patients
- discuss how recommendations for participation in sporting activities might be individualized for HCM patients
This continuing education (CE) activity is provided through collaboration between PCM Scientific and AffinityCE. This activity provides CE credit for physicians, physician assistants, nurses and nurse practitioners. A statement of participation is available to other attendees.
Physicians
This activity has been planned and implemented in accordance with the accreditation requirements and policies of the Accreditation Council for Continuing Medical Education (ACCME) through the joint providership of AffinityCE and PCM Scientific. AffinityCE is accredited by the ACCME to provide continuing medical education for physicians.
AffinityCE designates this enduring activity for a maximum of up to 1.0 AMA PRA Category 1 Credits™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
Physician Assistants
This activity has been planned and implemented in accordance with the accreditation requirements and policies of the Accreditation Council for Continuing Medical Education (ACCME) through the joint providership of AffinityCE and PCM Scientific. AffinityCE is accredited by the ACCME to provide continuing medical education for physicians.
AffinityCE designates this enduring activity for a maximum of up to 1.0 AMA PRA Category 1 Credits™. Physician assistants should claim only the credit commensurate with the extent of their participation in the activity.
Nurse Practitioners
This activity has been planned and implemented in accordance with the accreditation requirements and policies of the Accreditation Council for Continuing Medical Education (ACCME) through the joint providership of AffinityCE and PCM Scientific. AffinityCE is accredited by the ACCME to provide continuing medical education for physicians.
AffinityCE designates this enduring activity for a maximum of up to 1.0 AMA PRA Category 1 Credits™. Nurse practitioners should claim only the credit commensurate with the extent of their participation in the activity.
Nurses
Continuing Nursing Education is provided for this program through the joint providership between PCM Scientific and AffinityCE. AffinityCE is accredited as a provider of nursing continuing professional development by the American Nurses Credentialing Center’s Commission on Accreditation (ANCC). This activity provides a maximum of up to 1.0 contact hours of continuing nursing education credit.
CME Inquiries
For all CME policy-related inquiries, please contact us at [email protected].
Dr Matthew Martinez, Atlantic Health System, USA has received past grants from Bristol Myers Squibb and Cytokinetics.
Dr Michelle Michels, Associate Professor Erasmus University Medical Centre, NL has received past research grants from Alnylam, Bristol Myers Squibb, Cytokinetics and Pfizer.
AffinityCE staff, PCM Scientific staff, as well as planners and reviewers have no relevant financial interests to disclose.
Mitigation of relevant financial relationships
AffinityCE adheres to the ACCME’s Standards for Integrity and Independence in Accredited Continuing Education. Any individuals in a position to control the content of a CME activity, including faculty, planners, reviewers, or others, are required to disclose all relevant financial relationships with ineligible entities (commercial interests). All relevant financial relationships have been mitigated prior to the commencement of the activity.